Intralesional triamcinolone acetonide injection in hypertrophic skin surrounding the percutaneous titanium implant of a bone-anchored hearing aid
- PMID: 18252013
- DOI: 10.1017/S0022215107001673
Intralesional triamcinolone acetonide injection in hypertrophic skin surrounding the percutaneous titanium implant of a bone-anchored hearing aid
Abstract
Objective: We present a patient with persistent hypertrophic skin surrounding the percutaneous implant of a bone-anchored hearing aid system, successfully treated with intralesional applied corticosteroids.
Method: Case report and review of the world literature concerning bone-anchored hearing aid implantation and intralesional applied corticosteroids for the treatment of hypertrophic scars and keloids.
Results: Eight weeks after revision surgery to reduce surplus skin and subcutaneous scar tissue overgrowing the abutment, skin and subcutaneous scar tissue overgrowth reoccurred. As an alternative to yet another surgical procedure, the hypertrophic skin was treated with intralesional injections of triamcinolone acetonide. Three weeks after the treatment, a satisfying result was seen, and no subsequent relapse was observed.
Conclusion: To our knowledge, this is the first, photographically well documented case report of a patient with persistent hypertrophic skin surrounding a percutaneous bone-anchored hearing aid implant, successfully treated with intralesional applied corticosteroids.
Similar articles
-
An open, randomized, controlled, comparative study of the combined effect of intralesional triamcinolone acetonide and onion extract gel and intralesional triamcinolone acetonide alone in the treatment of hypertrophic scars and keloids.Dermatol Surg. 2008 Nov;34(11):1507-14. doi: 10.1111/j.1524-4725.2008.34314.x. Epub 2008 Sep 15. Dermatol Surg. 2008. PMID: 18798752 Clinical Trial.
-
Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: a preliminary study.Int J Dermatol. 2005 Sep;44(9):777-84. doi: 10.1111/j.1365-4632.2005.02633.x. Int J Dermatol. 2005. PMID: 16135153 Clinical Trial.
-
Soft tissue overgrowth in bone-anchored hearing aid patients: use of 8.5 mm abutment.J Laryngol Otol. 2011 Jun;125(6):576-9. doi: 10.1017/S0022215111000090. Epub 2011 Apr 1. J Laryngol Otol. 2011. PMID: 21457592
-
The use of corticosteroids to treat keloids: a review.Int J Low Extrem Wounds. 2008 Sep;7(3):137-45. doi: 10.1177/1534734608320786. Epub 2008 Jul 8. Int J Low Extrem Wounds. 2008. PMID: 18611924 Review.
-
The Safety and Efficacy of Intralesional Verapamil Versus Intralesional Triamcinolone Acetonide for Keloids and Hypertrophic Scars: A Systematic Review and Meta-analysis.Adv Skin Wound Care. 2020 Apr;33(4):1-7. doi: 10.1097/01.ASW.0000655476.10403.d6. Adv Skin Wound Care. 2020. PMID: 32195728
Cited by
-
Skin reactions caused by bone-anchored hearing aid (BAHA) implantation.J Otol. 2015 Dec;10(4):159-162. doi: 10.1016/j.joto.2016.01.001. Epub 2016 Feb 10. J Otol. 2015. PMID: 29937801 Free PMC article.
-
Switching from a percutaneous to a transcutaneous bone anchored hearing system: the utility of the fascia temporalis superficialis pedicled flap in case of skin intolerance.Eur Arch Otorhinolaryngol. 2015 Sep;272(9):2563-9. doi: 10.1007/s00405-015-3521-0. Epub 2015 Jan 30. Eur Arch Otorhinolaryngol. 2015. PMID: 25634062
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials